RxDoctor Payments Data

Kristina McCutchen

Physician Assistant · Omaha, NENPI 1588843544

Payments from drug & device makers

$4,345in general payments, 2019–2025

Across 257 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lundbeck LLC$288
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$287
  • Pfizer$207
  • Scilex Pharmaceuticals Inc.$203
  • Collegium Pharmaceutical, Inc.$194
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$4,345100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,345 in reported general payments places this provider in the 90th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl87$66,604
Xtampza ErOxycodone Myristate92$59,964
Nurtec OdtRimegepant Sulfate14$48,693
Nucynta ErTapentadol Hcl25$39,000
UbrelvyUbrogepant17$25,882
QuliptaAtogepant18$22,711
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen441$15,537
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen409$12,985
ReyvowLasmiditan Succinate14$9,410
MovantikNaloxegol Oxalate17$7,194
Buprenorphine35$6,711
Lidocaine43$5,574
Pregabalin197$4,881
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl38$3,921
Morphine Sulfate ErMorphine Sulfate100$2,631

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er$194$98,964117 claims
PfizerNurtec Odt$207$48,69314 claims
AbbVieUbrelvy, Qulipta$1,344$48,59335 claims
Lilly USA, LLCReyvow$81$9,41014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →